Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cilin Yan"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9167-9174 (2023)
Abstract Background Hepatic failure induced by immune checkpoint inhibitors (ICIs) has been reported in only a few case series and case reports. Objective We aimed to explore the association between ICIs and hepatic failure and characterize the clini
Externí odkaz:
https://doaj.org/article/08a579c516f04808a8865450ade40ef1
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5181-5194 (2023)
Abstract Aim This study aimed to systematically characterize transplant rejection after immune checkpoint inhibitors (ICIs) initiation in solid organ transplant recipients (SOTRs). Methods Data were extracted from the US FDA Adverse Event Reporting S
Externí odkaz:
https://doaj.org/article/fe5dce55f9e1495783683f9f90270687
Recently, there have been clinical reports of hepatitis B virus reactivation (HBVr) related with Janus kinase (JAK) inhibitors. However, there were no studies to investigate the association between HBVr and different JAK inhibitors. This study was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6b210d94465e4b3faa0a6970a7e6cc1
Publikováno v:
International journal of immunopathology and pharmacology. 36
Objective The haematopoietic cytopenia (HC) of the cyclin-dependent kinase (CDK)4/6 inhibitors was evaluated using the Food and Drug Administration Adverse Event Reporting System (FAERS). Method Data from 1 January 2015 to 31 December 2021 has been r
Background Although Immune checkpoint inhibitors (ICIs) associated liver damage usually presented as mild elevations of liver enzymes, hepatic failure induced by ICIs have been reported in only a few case series and case reports. Objective We aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8cc274a8e0921ad7180a3ec97f0f554
https://doi.org/10.21203/rs.3.rs-1855307/v1
https://doi.org/10.21203/rs.3.rs-1855307/v1
Autor:
Lin Wei, Xiangli Cui, Mingxing Guo, Cilin Yan, Ying Zhao, Li-Ying Sun, Zhi-Jun Zhu, Zhiqi Zhang
Publikováno v:
SSRN Electronic Journal.
Immune checkpoint inhibitors (ICIs) are widely used in different tumors due to their remarkable survival benefits, but efficacy and safety data are lacking in solid organ transplant recipients (SOTRs) who were treated with ICIs. The objective of our